Re: CRITICAL INFORMATION UPDATE-KUTAPRESSIN STATUS

[Guest guest]

Dear Marc and Cyn,

On behalf of and our family I would just like to thank you once again

for all you do. This is great work and wonderful news for all families whose

children either benefitted in the past , or who stand to benefit in the

future because of your continued tireless work. You have our deepest

respect. Way to go!

Best regards,

Doug McCreary

CRITICAL INFORMATION UPDATE-KUTAPRESSIN STATUS

> Update on the availability of Kutapressin:

>

>

> As some of you may know, the Parents Coalition has maintained the

lines

> of communication with Schwarz Phama with regard to the production and

> availability of Kutapressin. There is very good news on this front:

>

> Schwarz has completed the transfer of the production and distribution

> licensing rights to a new Pharma. All legal obstacles have been resolved

and

> the production issues and agreements with the previous suppliers have been

> resolved. Production has begun and Kutapressin, re-branded under a new

name

> due to legal and liability issues, will be available by the beginning of

> 2005 and perhaps sooner.

>

> As soon as I have more information that I am able to share, I will update

> all interested parties.

>

> I would like to extend my thanks to all those who assisted with this

effort.

>

> Marc Share

> Executive Director

> Parent Coalition

>

> _________________________________

>

>

>

>

> Responsibility for the content of this message lies strictly with

> the original author(s), and is not necessarily endorsed by or the

> opinion of the Research Institute.

>

>

[Guest guest]

Thank you for all that you do! You are sincerely appreciated.

Suzanne

To visit your group on the web, go to:

/

[Guest guest]

Well done Marc - Congrats!

CRITICAL INFORMATION UPDATE-KUTAPRESSIN STATUS

Update on the availability of Kutapressin:

As some of you may know, the Parents Coalition has maintained the lines

of communication with Schwarz Phama with regard to the production and

availability of Kutapressin. There is very good news on this front:

Schwarz has completed the transfer of the production and distribution

licensing rights to a new Pharma. All legal obstacles have been resolved and

the production issues and agreements with the previous suppliers have been

resolved. Production has begun and Kutapressin, re-branded under a new name

due to legal and liability issues, will be available by the beginning of

2005 and perhaps sooner.

As soon as I have more information that I am able to share, I will update

all interested parties.

I would like to extend my thanks to all those who assisted with this effort.

Marc Share

Executive Director

Parent Coalition

_________________________________

Responsibility for the content of this message lies strictly with

the original author(s), and is not necessarily endorsed by or the

opinion of the Research Institute.

[Guest guest]

many thanks and much appreciation, for this and all you do.

mary nunan